SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.52
+1.30%
Mkt Cap $33.17M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (5 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+99.1%
Consensus $7.00 vs current $3.52
NASDAQ·Healthcare·Biotechnology
$3.52
+1.30%
Mkt Cap $33.17M
Buy
4
Hold
0
Sell
0
Price Target (5 analysts)
$7.00
Range $7.00 – $7.00
+99.1%
Consensus $7.00 vs current $3.52